Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ulrich Mansmann

Showing results (291-300 of 317) with videos related to

Pageof 32
Sort By:
Blood Advances|September 17, 2021
A clinically applicable gene expression-based score predicts resistance to induction treatment in acute myeloid leukemiaChristian Moser, Vindi Jurinovic, Sabine Sagebiel-Kohler, et al.
Scientific Reports|August 15, 2019
Allelic Imbalance of Recurrently Mutated Genes in Acute Myeloid LeukaemiaAarif M N Batcha, Stefanos A Bamopoulos, Paul Kerbs, et al.
Oncotarget|July 27, 2018
Clonal heterogeneity of <i>FLT3</i>-ITD detected by high-throughput amplicon sequencing correlates with adverse prognosis in acute myeloid leukemiaKatrin Schranz, Max Hubmann, Egor Harin, et al.
Haematologica|August 27, 2016
Adults with Philadelphia chromosome-like acute lymphoblastic leukemia frequently have IGH-CRLF2 and JAK2 mutations, persistence of minimal residual disease and poor prognosisTobias Herold, Stephanie Schneider, Klaus H Metzeler, et al.
American Journal of Respiratory and Critical Care Medicine|May 2, 2013
Inhalation treatment with glutathione in patients with cystic fibrosis. A randomized clinical trialMatthias Griese, Matthias Kappler, Claudia Eismann, et al.
Blood Advances|September 23, 2022
Germline SNPs previously implicated as prognostic biomarkers do not associate with outcomes in intensively treated AMLAarif M N Batcha, Nele Buckup, Stefanos A Bamopoulos, et al.
The Journal of Clinical Investigation|July 24, 2025
A predictive endocrine resistance index accurately stratifies luminal breast cancer treatment responders and non-respondersGuokun Zhang, Vindi Jurinovic, Stephan Bartels, et al.
Leukemia|May 3, 2020
Clinical presentation and differential splicing of SRSF2, U2AF1 and SF3B1 mutations in patients with acute myeloid leukemiaStefanos A Bamopoulos, Aarif M N Batcha, Vindi Jurinovic, et al.
Clinical and Translational Radiation Oncology|May 20, 2024
Dummy run for planning of isotoxic dose-escalated radiation therapy for glioblastoma used in the PRIDE trial (NOA-28; ARO-2024-01; AG-NRO-06)Sebastian H Maier, Stephan Schönecker, Vasiliki Anagnostatou, et al.
The Lancet. Neurology|July 7, 2019
Safety and efficacy of epigallocatechin gallate in multiple system atrophy (PROMESA): a randomised, double-blind, placebo-controlled trialJohannes Levin, Sylvia Maaß, Madeleine Schuberth, et al.
Pageof 32

Showing results (291-300 of 317) with videos related to

Sort By:
Pageof 32
Blood Advances|September 17, 2021
A clinically applicable gene expression-based score predicts resistance to induction treatment in acute myeloid leukemiaChristian Moser, Vindi Jurinovic, Sabine Sagebiel-Kohler, et al.
Scientific Reports|August 15, 2019
Allelic Imbalance of Recurrently Mutated Genes in Acute Myeloid LeukaemiaAarif M N Batcha, Stefanos A Bamopoulos, Paul Kerbs, et al.
Oncotarget|July 27, 2018
Clonal heterogeneity of <i>FLT3</i>-ITD detected by high-throughput amplicon sequencing correlates with adverse prognosis in acute myeloid leukemiaKatrin Schranz, Max Hubmann, Egor Harin, et al.
Haematologica|August 27, 2016
Adults with Philadelphia chromosome-like acute lymphoblastic leukemia frequently have IGH-CRLF2 and JAK2 mutations, persistence of minimal residual disease and poor prognosisTobias Herold, Stephanie Schneider, Klaus H Metzeler, et al.
American Journal of Respiratory and Critical Care Medicine|May 2, 2013
Inhalation treatment with glutathione in patients with cystic fibrosis. A randomized clinical trialMatthias Griese, Matthias Kappler, Claudia Eismann, et al.
Blood Advances|September 23, 2022
Germline SNPs previously implicated as prognostic biomarkers do not associate with outcomes in intensively treated AMLAarif M N Batcha, Nele Buckup, Stefanos A Bamopoulos, et al.
The Journal of Clinical Investigation|July 24, 2025
A predictive endocrine resistance index accurately stratifies luminal breast cancer treatment responders and non-respondersGuokun Zhang, Vindi Jurinovic, Stephan Bartels, et al.
Leukemia|May 3, 2020
Clinical presentation and differential splicing of SRSF2, U2AF1 and SF3B1 mutations in patients with acute myeloid leukemiaStefanos A Bamopoulos, Aarif M N Batcha, Vindi Jurinovic, et al.
Clinical and Translational Radiation Oncology|May 20, 2024
Dummy run for planning of isotoxic dose-escalated radiation therapy for glioblastoma used in the PRIDE trial (NOA-28; ARO-2024-01; AG-NRO-06)Sebastian H Maier, Stephan Schönecker, Vasiliki Anagnostatou, et al.
The Lancet. Neurology|July 7, 2019
Safety and efficacy of epigallocatechin gallate in multiple system atrophy (PROMESA): a randomised, double-blind, placebo-controlled trialJohannes Levin, Sylvia Maaß, Madeleine Schuberth, et al.
Pageof 32